lynparza film-coated tablet 100mg
astrazeneca singapore pte ltd - olaparib - tablet, film coated - olaparib 100mg
lynparza film-coated tablet 150mg
astrazeneca singapore pte ltd - olaparib - tablet, film coated - olaparib 150mg
erwinase 10 000 u powder for solution for injection/infusion
porton biopharma limited - crisantaspase - powder for solution for injection/infusion - 10,000 unit(s) - asparaginase
tecartus suspension
gilead sciences canada inc - brexucabtagene autoleucel - suspension - 200000000cells - brexucabtagene autoleucel 200000000cells - antineoplastic agents
hydroxyurea medac 500 mg
tzamal bio-pharma ltd - hydroxycarbamide - capsules - hydroxycarbamide 500 mg - hydroxycarbamide - treatment of patient with chronic myeloid leukaemia (cml) in the chronic or accelerated phase of the disease.treatment of patients with essential thrombocytaemia or polycythaemia vera with a high risk for thrmboembolic complications.
tecartus suspension
gilead sciences canada inc - brexucabtagene autoleucel - suspension - 100000000cells - brexucabtagene autoleucel 100000000cells
enrylaze
jazz pharmaceuticals ireland limited - crisantaspase - precursor cell lymphoblastic leukemia-lymphoma - antineoplastic agents - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.
amsalyo 75 mg powder for concentration for solution infusion
eurocept international bv - amsacrine - powder for solution for infusion - amsacrine
abecma suspension
celgene inc - idecabtagene vicleucel - suspension - 520000000cells - idecabtagene vicleucel 520000000cells - gene therapy
carvykti suspension
janssen inc - ciltacabtagene autoleucel - suspension - 100000000cells - ciltacabtagene autoleucel 100000000cells